Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Resveratrol is a natural polyphenolic compound belonging to the stilbenoid group, commonly found in grapes, wine, peanuts, and Japanese knotweed (*Polygonum cuspidatum*). It functions as a calorie restriction mimetic, primarily known for activating **Sirtuin 1 (SIRT1)** and **AMP-activated protein kinase (AMPK)**, which subsequently improves mitochondrial function, enhances insulin sensitivity, and reduces oxidative stress. Resveratrol has been extensively investigated for its cardioprotective, anti-inflammatory, and neuroprotective properties. Clinical development spans various indications including obesity, metabolic syndrome, hypertriglyceridemia, and type 2 diabetes. Additionally, it is used as an excipient/matrix in medical devices, such as the SeQuent Please ReX drug-coated balloon, to facilitate the delivery of antiproliferative drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on resveratrol.